1. A multiple ascending dose study of CSL112, an infused formulation of ApoA‐I. (22nd October 2013) Authors: Easton, Rachael; Gille, Andreas; D'Andrea, Denise; Davis, Roslyn; Wright, Samuel D.; Shear, Charles Journal: Journal of clinical pharmacology Issue: Volume 54:Number 3(2014:Mar.) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients. Issue 4 (April 2018) Authors: Gille, Andreas; D'Andrea, Denise; Tortorici, Michael A.; Hartel, Gunter; Wright, Samuel D. Journal: Arteriosclerosis, thrombosis, and vascular biology Issue: Volume 38:Issue 4(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial. (25th October 2022) Authors: Gibson, C. Michael; Kazmi, Syed Hassan A.; Korjian, Serge; Chi, Gerald; Phillips, Adam T.; Montazerin, Sahar Memar; Duffy, Danielle; Zheng, Bo; Heise, Mark; Liss, Charles; Deckelbaum, Lawrence I.; Wright, Samuel D.; Gille, Andreas Journal: Journal of cardiovascular pharmacology and therapeutics Issue: Volume 27(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity. Issue 6 (2nd September 2016) Authors: Didichenko, Svetlana A.; Navdaev, Alexei V.; Cukier, Alexandre M.O.; Gille, Andreas; Schuetz, Patrick; Spycher, Martin O.; Thérond, Patrice; Chapman, M. John; Kontush, Anatol; Wright, Samuel D. Journal: Circulation research Issue: Volume 119:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Infusion of Reconstituted High‐Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial. Issue 8 (25th August 2015) Authors: Tricoci, Pierluigi; D'Andrea, Denise M.; Gurbel, Paul A.; Yao, Zhenling; Cuchel, Marina; Winston, Brion; Schott, Robert; Weiss, Robert; Blazing, Michael A.; Cannon, Louis; Bailey, Alison; Angiolillo, Dominick J.; Gille, Andreas; Shear, Charles L.; Wright, Samuel D.; Alexander, John H. Journal: Journal of the American Heart Association Issue: Volume 4:Issue 8(2015) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Infusion of Reconstituted High‐Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial. Issue 8 (August 2015) Authors: Tricoci, Pierluigi; D'Andrea, Denise M.; Gurbel, Paul A.; Yao, Zhenling; Cuchel, Marina; Winston, Brion; Schott, Robert; Weiss, Robert; Blazing, Michael A.; Cannon, Louis; Bailey, Alison; Angiolillo, Dominick J.; Gille, Andreas; Shear, Charles L.; Wright, Samuel D.; Alexander, John H. Journal: Journal of the American Heart Association Issue: Volume 4:Issue 8(2015) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A‐I [Human]) to Enhance Cholesterol Efflux Capacity. (19th November 2018) Authors: Gille, Andreas; Duffy, Danielle; Tortorici, Michael A.; Wright, Samuel D.; Deckelbaum, Lawrence I.; D'Andrea, Denise M. Journal: Journal of clinical pharmacology Issue: Volume 59:Number 3(2019) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux. Issue 5 (May 2020) Authors: Navdaev, Alexei V.; Sborgi, Lorenzo; Wright, Samuel D.; Didichenko, Svetlana A. Journal: Arteriosclerosis, thrombosis, and vascular biology Issue: Volume 40:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics and Safety of CSL112 (Apolipoprotein A‐I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function. Issue 5 (21st September 2018) Authors: Tortorici, Michael A.; Duffy, Danielle; Evans, Rebecca; Feaster, John; Gille, Andreas; Mant, Timothy G. K.; Wright, Samuel D.; D'Andrea, Denise Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 5(2019) Page Start: 628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A‐I and cholesterol efflux capacity in acute myocardial infarction patients. Issue 6 (23rd December 2020) Authors: Zheng, Bo; Duffy, Danielle; Tricoci, Pierluigi; Kastrissios, Helen; Pfister, Marc; Wright, Samuel D.; Gille, Andreas; Tortorici, Michael A. Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 6(2021) Page Start: 2558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗